España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Cocrystal Pharma
COCP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.07
0.0100
0.49%
Pre-Market: Nov 18, 5:13 PM EDT
Get Report
Comment
Cocrystal Pharma (COCP) Forecast
News
Earnings
Cocrystal Pharma (COCP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cocrystal Pharma (NASDAQ:COCP) Stock
Cocrystal Pharma Stock (NASDAQ: COCP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
Cocrystal Pharma shares are trading higher. T...
Benzinga Newsdesk
Wednesday, November 13, 2024
Cocrystal Pharma Q3 2024 GAAP EPS $(0.49) Bea...
Benzinga Newsdesk
Tuesday, November 05, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Thursday, September 26, 2024
Cocrystal Pharma Advances Oral Pan-Viral Prot...
Benzinga Newsdesk
Thursday, August 22, 2024
Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Cocrysta...
Benzinga Newsdesk
Monday, August 19, 2024
Cocrystal Pharma shares are trading higher af...
Benzinga Newsdesk
Cocrystal Pharma To Highlight Near-term Clini...
Benzinga Newsdesk
Wednesday, August 14, 2024
Cocrystal Pharma Q2 EPS $(0.53) Misses $(0.48...
Benzinga Newsdesk
Thursday, July 18, 2024
Cocrystal Pharma Reports Results From Single-...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Monday, May 13, 2024
Cocrystal Pharma Q1 2024 EPS $(0.39) Up From ...
Benzinga Newsdesk
Wednesday, May 01, 2024
Cocrystal Pharma Completes Enrollment Of 78 S...
Benzinga Newsdesk
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Thursday, April 04, 2024
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Thursday, March 28, 2024
Cocrystal Pharma Q4 EPS $(0.44) Beats $(0.60)...
Benzinga Newsdesk
Recap: Cocrystal Pharma Q4 Earnings
Benzinga Insights
Wednesday, March 20, 2024
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Tuesday, March 19, 2024
Cocrystal Pharma Receives Pre-IND Responses F...
Benzinga Newsdesk
Thursday, January 04, 2024
Cocrystal Pharma Provides An Update On The Cl...
Benzinga Newsdesk
Wednesday, January 03, 2024
HC Wainwright & Co. Maintains Buy on Cocrysta...
Benzinga Newsdesk
Thursday, December 21, 2023
Cocrystal Pharma Received Notice From Merck On December 15, 2023, Terminating Their Collaboration Agreement From January 2, 2019, Effective March 14, 2024, Ending Their Joint Development Of Influenza A/B Antiviral Compounds
Charles Gross
Wednesday, December 06, 2023
Cocrystal Pharma Announces First-Patient-In F...
Benzinga Newsdesk
Monday, December 04, 2023
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Wednesday, November 29, 2023
Cocrystal Pharma Announces The Presentation O...
Benzinga Newsdesk
Thursday, November 16, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, November 15, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, November 13, 2023
Recap: Cocrystal Pharma Q3 Earnings
Benzinga Insights
Cocrystal Pharma Q3 EPS $(0.41) Beats $(0.53)...
Benzinga Newsdesk
Tuesday, October 31, 2023
Cocrystal Pharma Receives UK MHRA Authorizati...
Benzinga Newsdesk
Wednesday, October 04, 2023
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Thursday, September 28, 2023
Cocrystal Pharma Doses First Subjects In Phas...
Benzinga Newsdesk
Tuesday, August 15, 2023
Analyst Ratings for Cocrystal Pharma
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Monday, August 14, 2023
Cocrystal Pharma Q2 EPS $(0.50) Beats $(0.58) Estimate
Happy Mohamed
Friday, August 11, 2023
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Tuesday, August 08, 2023
Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 As Norovirus Lead
Happy Mohamed
Friday, July 21, 2023
Board Member at Cocrystal Pharma Acquires Company Stock Options Worth 24,417 Shares
Benzinga Insights
Cocrystal Pharma Board Member Awarded $36K Worth of Stock Options
Benzinga Insights
Cocrystal Pharma Board Member Awarded $52K Worth of Stock Options
Benzinga Insights
Cocrystal Pharma Board Member Awarded $46K Worth of Stock Options
Benzinga Insights
Director at Cocrystal Pharma Acquires Company Stock Options Worth 7,333 Shares
Benzinga Insights
Thursday, June 15, 2023
Cocrystral Pharma May Offer, Sell Shares Of C...
Benzinga Newsdesk
Friday, June 02, 2023
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Cocryst...
Benzinga Newsdesk
Wednesday, May 31, 2023
Cocrystal Pharma Receives HREC Approval To In...
Benzinga Newsdesk
Wednesday, May 24, 2023
HC Wainwright & Co. Maintains Buy on Cocrysta...
Benzinga Newsdesk
Monday, May 15, 2023
Cocrystal Pharma Q1 EPS $(0.64) Misses $(0.59...
Benzinga Newsdesk
Thursday, May 04, 2023
Cocrystal Pharma Presents New Data From Its CC-42344 Phase 1 Influenza A Study At The 7th Annual ISIRV Antiviral Group Conference
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch